You are here

narcolepsy

Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1

Clinical Trials Arena

Thu, 04/25/24 - 11:26 am

clinical trials

Alkermes reports data from Phase Ib narcolepsy treatment trial

Clinical Trials Arena

Wed, 04/10/24 - 06:00 pm

clinical trials

Axsome's sleep disorder drug succeeds in late-stage trial, shares rise

Reuters

Mon, 03/25/24 - 11:22 am

Axsome Therapeutics

clinical trials

Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another

BioSpace

Fri, 02/9/24 - 11:18 am

clinical trials

Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680

Drugs.com

Tue, 10/10/23 - 11:47 pm

Takeda reports data from Phase II narcolepsy type 1 therapy trial

Clinical Trials Arena

Thu, 07/27/23 - 10:16 am

clinical trials

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

Fierce Pharma

Tue, 05/2/23 - 11:41 am

Scorpion Stings Harmony with Citizen’s Petition Threat for Sleepiness Drug

BioSpace

Thu, 03/30/23 - 10:03 am

Harmony Biosciences

Scorpion Capital

citizen petitions

Jazz loses appeal, will have patent delisted from the Orange Book

Endpoints

Mon, 02/27/23 - 07:09 pm

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Endpoints

Thu, 12/15/22 - 11:04 pm

Competition is on the horizon for costly narcolepsy treatments

Pharmaphorum

Wed, 12/14/22 - 10:26 am

Jazz Pharmaceuticals

Molina Healthcare

Harmony Biosciences

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

Fierce Pharma

Mon, 11/14/22 - 10:55 am

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Fierce Biotech

Thu, 07/28/22 - 10:59 am

Turnstone Biologics

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Fierce Pharma

Tue, 07/26/22 - 11:25 am

Takeda halts trial of orexin drug in narcolepsy on safety grounds

Pharmaforum

Wed, 10/6/21 - 10:52 am

clinical trials

Xywav Narcolepsy Drug Scores FDA Approval for Rare Sleep Disorder

Xtalks

Thu, 08/19/21 - 10:52 am

Jazz Pharmaceuticals

Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow

Endpoints

Wed, 07/22/20 - 10:42 am

Jazz Pharmaceuticals

Avadel's Once-Nightly Narcolepsy Drug Hits Three Co-Primary Endpoints in Late-Stage Trial

BioSpace

Mon, 04/27/20 - 07:26 pm

clinical trials

Upcoming events – Avadel takes on Jazz and Axovant awaits early results

EP Vantage

Fri, 02/14/20 - 10:35 am

Jazz Pharmaceuticals

Parkinson's Disease

Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug

Motley Fool

Wed, 01/22/20 - 11:06 pm

Jazz Pharmaceuticals

Pages